Lack of serologic evidence for an association between Cache Valley Virus infection and anencephaly and other neural tube defects in Texas. by Edwards, J. F. & Hendricks, K.
195 Vol. 3, No. 2, April–June 1997 Emerging Infectious Diseases
Dispatches
Anencephaly, spina bifida, and encephalocele
(the major types of neural tube defects) are
generally due to the failure of the neural tube to
close during early embryonic development (1).
Neural tube defects are among the most common
and most severe major birth defects. Anencephaly
is caused by failure of the anterior neuropore to
close during embryonic development and results
in total or partial absence of the cranial vault, the
covering skin, and the brain. Infants with
anencephaly are stillborn or die shortly after
birth. Spina bifida is caused by a disturbance in
the normal closure of neural walls and results in
spinal cord defects. Most infants with spina
bifida survive surgical repair of the defect with
residual neurologic handicaps of varying severity.
Encephaloceles are skull defects through which
skin-covered meninges, with or without brain
tissue, herniate. Small to moderately sized
encephaloceles are surgically correctable (1-4).
The prevalence of neural tube defects in the
United States has been steadily declining (5) and
is currently estimated to be six per 10,000 births.
The prevalence of anencephaly in the United
States has likewise declined and is now approxi-
mately three per 10,000 live births (4). A vital
record study of anencephaly in Texas showed that
from 1981 to 1986 the prevalence rate was 3.8 to
4.3 cases per 10,000 births (6). This study also
showed that in south Texas during this period the
average annual prevalence of anencephaly was
approximately 4.9 per 10,000 births. Women with
Hispanic surnames, three or more previous live
births, history of stillbirth, or residence in east or
south Texas were at increased risk for neural
tube defect–affected pregnancies. On the basis of
vital record data, the annual prevalence of anen-
cephaly in south Texas from 1981 through 1986
was approximately 4.9 per 10,000 live births.
In 1991 three babies with anencephaly were
born over a 36-hour period at a single hospital in
Cameron County, the southernmost county in
Texas (Brownsville is the county’s largest city).
The ensuing study, which used active multisource
case finding rather than vital records, showed that
the neural tube defect prevalence rate increased
from 14.7 per 10,000 births in 1986 to 1989 to
27.1 per 10,000 births in 1990 to 1991. The higher
rate was due largely to an increase in anence-
phaly cases. From 1986-89 to 1990-91, the average
annual anencephaly prevalence rate rose from
9.6 to 19.7 per 10,000 births (7,8).
Despite the high prevalence of neural tube
defects and the significant rate of illness
associated with them, much remains to be
learned about their complex multifactorial
etiology. Evidence suggests that these defects are
etiologically heterogeneous and may follow fetal
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insults such as maternal diabetes, hyperthermia,
folic acid deficiency, and anticonvulsant (val-
proate) therapy (9-13).
In 1987, before the increase in prevalence of
human anencephaly in south Texas, an outbreak
of severe congenital malformations of the central
nervous system and musculoskeletal system of
lambs occurred in San Angelo, Texas (14). At the
time of the outbreak, there was no active sur-
veillance of human birth defects in San Angelo,
and no reports were received of human birth
defects in the area. The ovine problem was later
found to be caused by in utero infection by Cache
Valley Virus (CVV). Although this insect-borne
bunyavirus had been known to commonly infect
North American ruminants (15), it was not
thought to be of clinical significance.
Experimentally, it was determined that CVV
infection of the dam in early gestation and
transplacental infection of the ovine fetus could
produce severe brain malformations and arthro-
gryposis multiplex congenita, an anomaly
characterized by limbs fixed in contracture (14).
Central nervous system malformations associated
with experimental and spontaneous CVV
infection include hydrocephalus, hydranen-
cephaly, porencephaly, micrencephaly, and micro-
melia. After the syndrome was characterized,
outbreaks of CVV-induced malformations in
ruminants were diagnosed throughout North
America, and work by Calisher and Sever (16)
also linked CVV to congenital cases of human
macrocephaly in the United States.
Other bunyaviruses can cause identical con-
genital malformations of the central nervous
system in experimentally infected livestock (14).
Human congenital morbidity has also been corre-
lated with maternal antibody to bunyaviruses (16).
A recent study correlated both human microcephaly
and macrocephaly with antibody to Tenshaw virus
in mothers of infants with these illnesses.
 We decided to test the hypothesis that CVV
infection was related to human neural tube defects.
Public concern regarding the 1990 to 1991 cluster
in Brownsville, Texas, (7) had resulted in an
ongoing project in the 14 Texas counties that
border Mexico. A neural tube defect surveillance
and folic acid intervention project were imple-
mented in 1993, and a case-control study was
begun in mid-1995. Sera from case patients had
been banked before the case-control study began.
Sera from 74 women who lived in the Texas
border counties and had neural tube defect–
affected pregnancies (36 with spina bifida, 34
with anencephaly, and 4 with encephalocele)
from 1993 through early 1995 were examined for
a possible link between CVV and neural tube
defects. With a standard microtiter serum dilu-
tion neutralization test (17), the sera were screened
at final dilutions of 1:2, 1:4, 1:8, and 1:16. The virus
used in all tests was the prototype CVV (strain
6V-633, provided by the Centers for Disease
Control and Prevention [CDC], Ft. Collins,
Colorado), which had been passaged one time in
Vero cells after receipt from CDC. Controls
included sera from women of undetermined CVV
status who gave birth to healthy infants in south
Texas [8]; sera collected from sheep before CVV
infection [3]; and normal macaque [4], horse [1],
and bovine [1] sera. Positive controls included
CVV–convalescent-phase ovine sera [3] and CVV
antibody–positive sera from a horse and a cow.
No serum neutralization activity for CVV was
detected in sera from women who gave birth to
healthy infants or infants with neural tube
defects. Had CVV infection been present in these
women during gestation, CVV antibody would
have been detectable postpartum.
Before this study, the relationship between
CVV and human neural tube defects was unknown.
Testing an adequate number of controls is critical
when seroepidemiology is used to establish a
causal relationship between an agent and a low
frequency event or malformation, particularly
when case patients have evidence of antibodies
against the agent of interest. In this study, there
was no evidence that CVV was related to the
neural tube defect cases observed in Texas from
1993 through early 1995. Had CVV antibodies
been detected in serum from women with neural
tube defect–affected pregnancies, it would have
been necessary to test control sera from age- and
location-matched women with normal births.
The average annual neural tube defect preva-
lence rate in Cameron County, Texas, for 1992 to
1995 has returned to the 1986 to 1989 rate of
approximately 14-15 cases per 10,000 births.
These data suggest that CVV is not involved in
the induction of human neural tube defects
during nonepidemic periods but do not preclude
CVV involvement during epidemics. CVV may
still be involved in induction of other human mal-
formations. Other endemic bunyaviruses may be
involved in the pathogenesis of neural tube
defects and of other congenital nervous system or
musculoskeletal malformations (18,19). It would197 Vol. 3, No. 2, April–June 1997 Emerging Infectious Diseases
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seem valid to continue to investigate the relation-
ship of CVV and other arboviruses to human
developmental illness and death rate. Because of
the wide variety of defects caused by these viruses,
laboratory models of fetal infection by the
Bunyaviridae would facilitate the understanding
of viral teratogenesis mechanisms in humans.
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